Additional menu

BuyModa.net

RESEARCH / OCCUPATIONAL ALERTNESS

Modafinil and Shift Work: What 33 Studies Actually Measured

What the controlled trials of night-shift nurses and doctors, pilots, and soldiers actually show about modafinil, alertness, and staying safe on the job.

Author Shane Hellmrich Studied health promotion at Curtin University
Published
Fact check Reviewed Last updated
Citation
Suggested citation Hellmrich, S. (2026). Modafinil and Shift Work: What 33 Studies Actually Measured BuyModa. Retrieved from https://buymoda.net/modafinil-shift-work-research/

Across 33 controlled trials and field studies that cover shift-working nurses and doctors, emergency physicians, helicopter and fighter pilots, and soldiers held awake for 40 to 64 hours, a single 200 mg dose of modafinil restores alertness and higher-order cognition during night work, but it never returns them to a fully rested baseline.

In the landmark shift work trial, modafinil cut the share of workers reporting an accident or near-accident on the commute home from 54% to 29%.1 It lengthens objective sleep latency by roughly 2 to 3 minutes on the Multiple Sleep Latency Test, reduces attention lapses, and improves executive function across simulated and real night shifts.

Aviation studies show it preserves 4 to 6 of 8 flight-simulator manoeuvres through 37 to 40 hours awake.1314

Residual sleepiness persists in every trial. Adverse events are not trivial (headache 34% versus 23% on placebo; nausea 11% versus 3%),33 and military work records a subtler hazard: users sustain performance while overestimating how well they are doing.23

Methodology

We searched PubMed, PubMed Central and journal records for controlled trials, field studies and evidence syntheses of modafinil or armodafinil in occupational and sustained-operations settings: shift work disorder, simulated night shift, night-shift healthcare, aviation, military continuous operations and driving safety. Each study was verified field-by-field against its source record and carries a PMID or DOI; no study is included from memory. We report each study its own primary endpoint and effect. We did not compute a new pooled meta-analytic estimate, so this is a structured synthesis of published work, not a fresh clinical study, and not medical advice.

Background: the occupational problem

Night and rotating shifts push work into the body circadian low, the window in the small hours when alertness, reaction time and mood are at their worst regardless of motivation or experience.

Modafinil is a wakefulness-promoting medicine used for excessive sleepiness in narcolepsy, residual sleepiness in obstructive sleep apnoea, and shift work disorder.32 The occupational question is narrower than the clinical one. It is not whether the drug can raise alertness in a sleep laboratory, but whether that benefit carries over to real rosters, real cabs and real cockpits, and at what cost in side effects and self-judgement.

The studies below are grouped by how close they sit to that real-world test, moving from regulated shift work disorder trials, through simulated night shifts, to field studies in working doctors, pilots and soldiers. Read together they tell a single story: a real, repeatable gain in alertness that stops short of a full recovery, paired with a handful of caveats that matter most in the safety-critical jobs where the drug is most tempting.

Shift work disorder: the clinical trials

Modafinil (200 mg) is approved for excessive sleepiness in shift work disorder; armodafinil (150 mg) followed. Eight randomised controlled trials anchor the evidence, and the direction is consistent: lower subjective sleepiness, longer objective sleep latency, and better global functioning, with a residual sleepiness gap that no trial closes.

The American Academy of Sleep Medicine recommends modafinil to improve alertness during night-shift work in this population.32 For where the drug is legal to import and use, see our modafinil legal status by country reference.

StudyDrug and dosenPopulationKey result
Czeisler 2005 (NEJM)Modafinil 200 mg209Chronic shift work sleep disorderCommute accidents and near-accidents 29% versus 54% placebo; clinical improvement 74% versus 36%
Czeisler 2009 (Mayo Clin Proc)Armodafinil 150 mg254Permanent and rotating night workersMSLT latency 2.3 to 5.3 min versus 2.4 to 2.8 placebo; CGI-C improved 79% versus 59%
Erman 2007 (Prim Care Companion)Modafinil 200 or 300 mg278Shift work sleep disorder (38% healthcare)FOSQ functioning +2.3 (300 mg) versus +1.6 placebo; mental quality-of-life +3.2 to 3.7 versus +0.7
Erman 2012 (Prim Care Companion CNS)Armodafinil 150 mg383Adults 18 to 65 with shift work disorderSheehan disability minus 6.8 versus minus 4.5; FOSQ-10 +3.6 versus +2.7
Erman 2011 (J Occup Environ Med)Armodafinil 150 mgn/aLate-shift functioningImproved alertness and functioning late in shift and overall versus placebo
Harsh 2014 (Curr Med Res Opin)Armodafinil 150 mgn/aBy shift durationEfficacy and tolerability held across 8, 10 and 12 hour shifts
Tembe 2011 (Neurol Res Int)Armo 150 vs Moda 200211Indian night-shift workersResponder rate 72.1% (armodafinil) versus 74.3% (modafinil); comparable
Drake 2014 (Sleep)Armodafinil 150 mg20Night workers with shift work disorderMSLT 3.7 to 9.7 min; reduced driving-simulator lane deviation
Source: BuyModa synthesis of shift work disorder randomised controlled trials. Identifiers in the reference list.

Simulated night-shift laboratory studies

Controlled laboratory studies rotate healthy volunteers onto night schedules and measure the Maintenance of Wakefulness Test, psychomotor vigilance and executive function.

Walsh (2004) ran 32 volunteers through four consecutive simulated night shifts, and modafinil improved alertness, vigilance and all three executive-function tasks.9 Hart (2006) ran a 23-day residential study in which modafinil reversed the night-shift decline in cognition and mood seen on placebo, with little disruption to daytime recovery sleep at 200 mg.10

StudynDesignResult
Walsh 2004 (Sleep)32Four consecutive simulated night shiftsHigher MWT latency, fewer PVT lapses, improved all three executive-function tasks versus placebo
Hart 2006 (Neuropsychopharmacology)1123-day residential day and night crossoverReversed night-shift cognitive and mood decline; few sleep effects at 200 mg
Source: BuyModa synthesis of simulated night-shift laboratory studies.

Doctors, surgeons and emergency physicians

Healthcare is the archetypal high-stakes night-shift job, and two randomised trials tested modafinil directly on sleep-deprived doctors. The recurring pattern is a dissociation: higher-order cognition improves while manual skill does not.

Gill (2006) found improved sustained attention and working memory in emergency physicians after a night shift, but harder sleep onset afterward.11 Sugden (2012) gave modafinil to 39 sleep-deprived resident doctors: working memory and planning improved, but surgical and psychomotor skill was unchanged.12

StudynPopulationResult
Gill 2006 (Acad Emerg Med)approx 24Emergency physicians, post night shiftImproved sustained attention and working memory; delayed post-shift sleep onset
Sugden 2012 (Ann Surg)39Sleep-deprived resident doctorsWorking memory and planning improved; surgical psychomotor skill unchanged
Source: BuyModa synthesis of physician and surgeon studies.

Aviation, military and sustained operations

The deepest evidence base is military, because armed forces need alert operators through 40 hours or more without sleep. Helicopter and fighter-pilot simulator studies preserve most flight manoeuvres deep into sleep deprivation.1314

In 60 to 64 hour continuous-work protocols the drug sustains reaction time, reasoning and memory and nearly abolishes microsleeps.2021

Head-to-head it matches dextroamphetamine for pilots without the aeromedical side effects,15 and it outlasts caffeine in air-crew vigilance.25 A 2022 military review still concludes its use as a stimulant outside sleep-deprivation contexts should be restricted.26

StudynPopulationHours awakeResult
Caldwell 2000 (Psychopharmacology)6Military helicopter pilots40 hPreserved 4 of 6 flight manoeuvres; benefit greatest at the circadian trough (0330 to 1130)
Caldwell 2004 (Aviat Space Environ Med)10USAF F-117 fighter pilots37 hPreserved 6 of 8 simulator manoeuvres; strongest 24 to 32 h awake
Estrada 2012 (Aviat Space Environ Med)18Military helicopter pilotsn/aAlertness, judgement and situation awareness consistently above placebo; comparable to dextroamphetamine, no aeromedical side effects
Pigeau 1995 (J Sleep Res)41Military, continuous operations64 hSustained reaction time, reasoning and short-term memory above placebo; fewer side effects than amphetamine
Lagarde 1995 (Fundam Clin Pharmacol)8French military volunteers60 hNear-total absence of microsleep episodes versus progressive microsleeps on placebo
Wesensten 2005 (J Sleep Res)48Healthy adults (sleep-deprivation model)85 hRestored psychomotor and executive performance toward non-deprived levels
Killgore 2009 (Sleep)n/aSleep-deprived adults44 to 77 hSustained executive functions during deprivation versus placebo
Wingelaar-Jagt 2023 (J Psychopharmacol)32Royal Netherlands Air Force crewn/aReduced PVT vigilance decline; effect longer-lasting than caffeine, out to 8 h post-dose
Wu 2018 (Mil Med Res, review)n/aAstronautsn/aAbout 75% of astronauts reported using caffeine or modafinil during missions
Source: BuyModa synthesis of sustained-operations trials.

The commute-home danger window

A distinctly occupational endpoint is that night workers crash driving home, not at work. The landmark Czeisler trial measured this directly,1 and driving-simulator studies confirm modafinil reduces lane deviation after sleep loss.828

The same studies flag a catch: drivers rate their own driving as better than it measurably is. The alertness is real; the self-assessment is not fully reliable. Anyone importing for shift use should also read our modafinil shipping notes and the broader modafinil statistics collection.

StudynResult
Drake 2014 (Sleep)20Reduced simulated-driving lane deviation and off-road events; MSLT 3.7 to 9.7 min
Gurtman 2008 (Hum Psychopharmacol)16Reduced lane deviation versus placebo; improved self-rated driving (possible overconfidence)
Source: BuyModa synthesis of driving-simulator studies.

Limitations

Limitations

  • Alertness is improved, not normalised. Every shift work disorder trial leaves a residual sleepiness gap. Modafinil is a partial countermeasure, not a substitute for sleep.
  • Adverse events are not trivial. Pooled safety data across six trials give headache 34% versus 23% placebo and nausea 11% versus 3%.33 The Cochrane review rates the benefit as moderate and flags headache, nausea, insomnia and anxiety.29
  • Overconfidence is documented. Under sleep deprivation, users can sustain performance while overestimating it,2324 a real hazard for self-assessed fitness to drive or operate.
  • Manual skill is not enhanced. Working memory and vigilance improve; surgical and fine-motor performance in sleep-deprived doctors does not.12
  • This is a synthesis of published trials, not a controlled study, and not medical advice. Dosing decisions belong to a prescribing clinician.

References

  1. Czeisler, C. A., et al. (2005). Modafinil for excessive sleepiness associated with shift-work sleep disorder. New England Journal of Medicine, 353(5), 476-486. PubMed
  2. Czeisler, C. A., et al. (2009). Armodafinil for treatment of excessive sleepiness associated with shift work disorder: A randomized controlled study. Mayo Clinic Proceedings, 84(11), 958-972. PubMed
  3. Erman, M. K., & Rosenberg, R. (2007). Modafinil for excessive sleepiness associated with chronic shift work sleep disorder. Primary Care Companion to the Journal of Clinical Psychiatry, 9(3), 188-194. PubMed
  4. Erman, M. K., Yang, R., & Seiden, D. J. (2012). The effect of armodafinil on patient-reported functioning and quality of life in patients with excessive sleepiness associated with shift work disorder. Primary Care Companion for CNS Disorders, 14(4). PubMed
  5. Erman, M. K., Seiden, D. J., Yang, R., & Dammerman, R. (2011). Efficacy and tolerability of armodafinil: Effect on clinical condition late in the shift and overall functioning of patients with excessive sleepiness associated with shift work disorder. Journal of Occupational and Environmental Medicine, 53(12), 1460-1465. PubMed
  6. Harsh, J., Yang, R., & Hull, S. G. (2014). The impact of shift duration on the efficacy and tolerability of armodafinil in patients with excessive sleepiness associated with shift work disorder. Current Medical Research and Opinion, 30(5), 945-951. PubMed
  7. Tembe, D. V., et al. (2011). Armodafinil versus modafinil in patients of excessive sleepiness associated with shift work sleep disorder: A randomized double blind multicentric clinical trial. Neurology Research International, 2011, 514351. PubMed
  8. Drake, C., Gumenyuk, V., Roth, T., & Howard, R. (2014). Effects of armodafinil on simulated driving and alertness in shift work disorder. Sleep, 37(12), 1987-1994. PubMed
  9. Walsh, J. K., Randazzo, A. C., Stone, K. L., & Schweitzer, P. K. (2004). Modafinil improves alertness, vigilance, and executive function during simulated night shifts. Sleep, 27(3), 434-439. PubMed
  10. Hart, C. L., et al. (2006). Modafinil attenuates disruptions in cognitive performance during simulated night-shift work. Neuropsychopharmacology, 31(7), 1526-1536. PubMed
  11. Gill, M., Haerich, P., Westcott, K., Godenick, K. L., & Tucker, J. A. (2006). Cognitive performance following modafinil versus placebo in sleep-deprived emergency physicians: A double-blind randomized crossover study. Academic Emergency Medicine, 13(2), 158-165. PubMed
  12. Sugden, C., et al. (2012). Effect of pharmacological enhancement on the cognitive and clinical psychomotor performance of sleep-deprived doctors: A randomized controlled trial. Annals of Surgery, 255(2), 222-227. PubMed
  13. Caldwell, J. A., Caldwell, J. L., Smythe, N. K., & Hall, K. K. (2000). A double-blind, placebo-controlled investigation of the efficacy of modafinil for sustaining the alertness and performance of aviators: A helicopter simulator study. Psychopharmacology, 150(3), 272-282. PubMed
  14. Caldwell, J. A., Caldwell, J. L., Smith, J. K., & Brown, D. L. (2004). Modafinil's effects on simulator performance and mood in pilots during 37 h without sleep. Aviation, Space, and Environmental Medicine, 75(9), 777-784. PubMed
  15. Estrada, A., et al. (2012). Modafinil as a replacement for dextroamphetamine for sustaining alertness in military helicopter pilots. Aviation, Space, and Environmental Medicine, 83(6), 556-564. PubMed
  16. Wesensten, N. J., et al. (2002). Maintaining alertness and performance during sleep deprivation: Modafinil versus caffeine. Psychopharmacology, 159(3), 238-247. PubMed
  17. Wesensten, N. J., Killgore, W. D. S., & Balkin, T. J. (2005). Performance and alertness effects of caffeine, dextroamphetamine, and modafinil during sleep deprivation. Journal of Sleep Research, 14(3), 255-266. PubMed
  18. Killgore, W. D. S., Kahn-Greene, E. T., Grugle, N. L., Killgore, D. B., & Balkin, T. J. (2009). Sustaining executive functions during sleep deprivation: A comparison of caffeine, dextroamphetamine, and modafinil. Sleep, 32(2), 205-216. PubMed
  19. Killgore, W. D. S., et al. (2008). Restoration of risk-propensity during sleep deprivation: Caffeine, dextroamphetamine, and modafinil. Aviation, Space, and Environmental Medicine, 79(9), 867-874. PubMed
  20. Lagarde, D., & Batejat, D. (1995). Interest of modafinil, a new psychostimulant, during a sixty-hour sleep deprivation experiment. Fundamental & Clinical Pharmacology, 9(3), 271-279. PubMed
  21. Pigeau, R., et al. (1995). Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work. I. Effects on mood, fatigue, cognitive performance and body temperature. Journal of Sleep Research, 4(4), 212-228. PubMed
  22. Buguet, A., Montmayeur, A., Pigeau, R., & Naitoh, P. (1995). Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work. II. Effects on two nights of recovery sleep. Journal of Sleep Research, 4(4), 229-241. Journal
  23. Baranski, J. V., & Pigeau, R. A. (1997). Self-monitoring cognitive performance during sleep deprivation: Effects of modafinil, d-amphetamine and placebo. Journal of Sleep Research, 6(2), 84-91. PubMed
  24. Baranski, J. V., Pigeau, R., Dinich, P., & Jacobs, I. (2004). Effects of modafinil on cognitive and meta-cognitive performance. Human Psychopharmacology, 19(5), 323-332. PubMed
  25. Wingelaar-Jagt, Y. Q., Bottenheft, C., Riedel, W. J., & Ramaekers, J. G. (2023). Effects of modafinil and caffeine on night-time vigilance of air force crewmembers: A randomized controlled trial. Journal of Psychopharmacology, 37(3), 264-274. PubMed
  26. Wingelaar-Jagt, Y. Q., Wingelaar, T. T., Riedel, W. J., & Ramaekers, J. G. (2022). A state-of-the-art review on the use of modafinil as a performance-enhancing drug in the context of military operationality. Military Medicine, 187(11-12), 1286-1298. PubMed
  27. Wu, B., et al. (2018). On-orbit sleep problems of astronauts and countermeasures. Military Medical Research, 5(1), 17. PubMed
  28. Gurtman, C. G., Broadbear, J. H., & Redman, J. R. (2008). Effects of modafinil on simulator driving and self-assessment of driving following sleep deprivation. Human Psychopharmacology, 23(8), 681-692. PubMed
  29. Liira, J., et al. (2014). Pharmacological interventions for sleepiness and sleep disturbances caused by shift work. Cochrane Database of Systematic Reviews, (8), CD009776. PubMed
  30. Savarese, M., & Di Perri, M. C. (2020). Excessive sleepiness in shift work disorder: A narrative review of the last 5 years. Sleep and Breathing, 24(1), 297-310. PubMed
  31. Conway-Jones, R., et al. (2023). A scoping review of the evidence for the impact of pharmacological and non-pharmacological interventions on shift work related sleep disturbance in an occupational setting. Wellcome Open Research, 7, 135. PubMed
  32. Morgenthaler, T. I., et al. (2007). Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. Sleep, 30(11), 1445-1459. PubMed
  33. Roth, T., et al. (2007). Evaluation of the safety of modafinil for treatment of excessive sleepiness. Journal of Clinical Sleep Medicine, 3(6), 595-602. PubMed

For current vendor recommendations informed by this research, see the vendor comparison.